Aberrant Proliferation in CXCR7+ Endothelial Cells via Degradation of the Retinoblastoma Protein
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant Proliferation in CXCR7+ Endothelial Cells via Degradation of the Retinoblastoma Protein
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e69828
Publisher
Public Library of Science (PLoS)
Online
2013-07-24
DOI
10.1371/journal.pone.0069828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemokine and Chemokine Receptor Expression in Kidney Tumors: Molecular Profiling of Histological Subtypes and Association With Metastasis
- (2012) Jeffrey C. Gahan et al. JOURNAL OF UROLOGY
- Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells
- (2012) K E Luker et al. ONCOGENE
- Antagonism of CXCR7 attenuates chronic hypoxia–induced pulmonary hypertension
- (2012) Ecaterina Sartina et al. PEDIATRIC RESEARCH
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells
- (2011) Justin Monnier et al. EUROPEAN JOURNAL OF CANCER
- Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis
- (2011) Mitsuko Furuya et al. GYNECOLOGIC ONCOLOGY
- Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature
- (2011) Roberto Würth et al. JOURNAL OF NEUROIMMUNOLOGY
- A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis
- (2011) Xin Yin et al. Molecular Cancer
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Antiangiogenic agents and targets: A perspective
- (2010) Beverly A. Teicher BIOCHEMICAL PHARMACOLOGY
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
- (2010) K. Hattermann et al. CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Current views on the function of the lymphatic vasculature in health and disease
- (2010) Y. Wang et al. GENES & DEVELOPMENT
- The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7
- (2010) Stéphanie Gravel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemokine receptor CXCR7 regulates the invasion,angiogenesis and tumor growth of human hepatocellular carcinoma cells
- (2010) Ke Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of Lymphatic Vessels in Tumor Immunity: Passive Conduits or Active Participants?
- (2010) Amanda W. Lund et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
- (2010) Ulrike Naumann et al. PLoS One
- CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
- (2009) A. Levoye et al. BLOOD
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- Regulation of the retinoblastoma proteins by the human herpesviruses
- (2009) Adam J Hume et al. Cell Division
- Differential Ligand Binding to a Human Cytomegalovirus Chemokine Receptor Determines Cell Type–Specific Motility
- (2009) Jennifer Vomaske et al. PLoS Pathogens
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- CXCR7, CXCR4 and CXCL12: An eccentric trio?
- (2008) Marcus Thelen et al. JOURNAL OF NEUROIMMUNOLOGY
- Agonist-selective mechanisms of GPCR desensitization
- (2007) E Kelly et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started